Drug Stocks Review: Abbott Laboratories, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline

Lakeway, TX -- (SBWIRE) -- 02/28/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Abbott Laboratories(NYSE:ABT) fell 0.09% and is trading at $34.23. Abbott Laboratories (Abbott), is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products. Abbott operates in four business segments: diagnostics, medical devices, nutritionals and generic pharmaceuticals. Geographically, 30% of its revenue is generated in the United States; 30% in Western Europe, Canada, Japan and Australia, and 40% in the economies, including India, China, Russia and Brazil.

How Should Investors Trade ABT After The Recent Movement? Find Out Here

Johnson & Johnson(NYSE:JNJ) is lower 0.03% and is trading at $76.30. Johnson & Johnson is a holding company. The Company, along with its subsidiaries, is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics.

Is JNJ Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Gilead Sciences, Inc.(NASDAQ:GILD) added 0.40% and is trading at $43.06. Gilead Sciences, Inc. (Gilead) is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Gilead’s primary areas of focus include human immunodeficiency virus (HIV)/AIDS, liver diseases, such as hepatitis B and C and cardiovascular/metabolic and respiratory conditions.

Is GILD a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

GlaxoSmithKline plc (ADR)(NYSE:GSK) is lower 0.47% and is trading at $44.06. GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products.

How Should Investors Trade GSK After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.